(Q40521722)
Statements
Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial (English)
G Bianchini
L Pusztai
Y-H Im
L-M Tseng
M-C Liu
E Galeota
D Magazzù
J de la Haba-Rodríguez
D-Y Oh
B Poirier
J L Pedrini
V Semiglazov
P Valagussa
19 September 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference